December 15, 2025

Teva Pharmaceutical (TEVA) Stock Analysis: Exploring Growth Potential Amidst Robust Analyst Ratings

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a prominent player in the global pharmaceutical landscape, primarily recognized for its expansive portfolio of generic and specialty medicines. With a market capitalization..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Deep Dive into its 23.94% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the healthcare sector, specifically within the biotechnology industry. With a robust market capitalization of $52.52 billion, this Massachusetts-based..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating the 5.61% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) continues to captivate the attention of investors as it stands at the forefront of the biotechnology industry with a robust portfolio and promising growth potential...

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant Poised for a 11.50% Upside

For investors seeking exposure in the healthcare sector, Cencora, Inc. (NYSE: COR) presents a compelling opportunity. Formerly known as AmerisourceBergen Corporation, the company rebranded as Cencora in August 2023, marking..

Encompass Health Corporation (EHC) Stock Analysis: A Compelling 31% Upside Potential with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, operates within the medical care facilities industry. Headquartered in Birmingham, Alabama, the company specializes in post-acute healthcare services,..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a 18.46% Potential Upside for Investors

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of investors, with its current financial metrics and strategic positioning in the biotechnology sector suggesting a promising potential upside of 18.46%...

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with 15% Upside Potential

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and promising future projections. With a market capitalization of $218.36..

Haleon plc (HLN) Investor Outlook: Analyzing the 21.95% Potential Upside

For investors eyeing opportunities in the healthcare sector, Haleon plc (NYSE: HLN) presents itself as a notable contender. With a market capitalization of $42.39 billion, this UK-based company is a..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a 14% Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) stands as a compelling entity in the biotechnology sector, making waves with its innovative therapies targeting serious and rare diseases. Headquartered in Bridgewater, New Jersey, Insmed’s..

Alcon Inc. (ALC) Stock Analysis: Evaluating a 16.87% Potential Upside for Investors

Alcon Inc. (NYSE: ALC), a leader in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors with its robust market presence and promising growth..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Buy Ratings and Potential 7.14% Upside

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, stands as a formidable player in the drug manufacturing industry. Boasting a robust market cap of $250.53 billion,..

The Cooper Companies, Inc. (COO) Stock Analysis: Navigating a 10.26% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has long been a staple for investors looking to explore opportunities in medical instruments and supplies. With..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 24.28% Potential Upside in the Healthcare Sector

Baxter International Inc. (NYSE: BAX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.84 billion, Baxter..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a Promising 5.77% Upside

Investors looking for opportunities in the healthcare sector may want to keep a close watch on GE HealthCare Technologies Inc. (NYSE: GEHC). As a key player in the health information..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Growth Potential Amidst a 9.87% Upside

Intuitive Surgical, Inc. (ISRG), a powerhouse in the healthcare sector, stands at the forefront of medical innovation with its cutting-edge surgical robotic systems. Headquartered in Sunnyvale, California, Intuitive Surgical has..

Pfizer, Inc. (PFE) Stock Analysis: Can an 11.86% Upside Entice Investors Amidst a Robust Dividend Yield?

Pfizer, Inc. (NYSE: PFE), a behemoth in the healthcare sector, stands as a cornerstone of the biopharmaceutical industry. With a market capitalization of $146.98 billion, Pfizer’s extensive portfolio and strategic..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 35.70% Potential Upside in the Healthcare Sector

Zoetis Inc. (ZTS), a key player in the healthcare sector specializing in animal health, is capturing investor attention with a compelling 35.70% potential upside, according to analysts’ average target price...

HealthEquity, Inc. (HQY) Stock Analysis: A 25.15% Potential Upside Makes This Healthcare Play Worth Watching

For investors seeking exposure in the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents an intriguing opportunity. This Utah-based company, a leader in health information services, is pioneering the way consumers..

Natera, Inc. (NTRA) Stock Analysis: Is There Room for Growth Beyond Its $32.35 Billion Market Cap?

Natera, Inc. (NASDAQ: NTRA) stands as a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a compelling market capitalization of $32.35 billion, the company..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 12.57% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.66 billion, Revvity is positioned..

Search

Funds

December 15, 2025

Search

Funds

December 15, 2025

FTSE 100

Funds